Log in to save to my catalogue

Pharmacogenomics and clinical response to antipsychotic treatment. Expectations vs reality

Pharmacogenomics and clinical response to antipsychotic treatment. Expectations vs reality

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_13dcae0323eb42c2b7c96a1d856a4262

Pharmacogenomics and clinical response to antipsychotic treatment. Expectations vs reality

About this item

Full title

Pharmacogenomics and clinical response to antipsychotic treatment. Expectations vs reality

Publisher

Paris: Cambridge University Press

Journal title

European psychiatry, 2023-03, Vol.66 (S1), p.S1013-S1013

Language

English

Formats

Publication information

Publisher

Paris: Cambridge University Press

More information

Scope and Contents

Contents

IntroductionAccording to the ICD-10 classification system, manic episodes in bipolar affective disorder (BAD) are typically characterised by sudden onset of symptoms and a duration between two weeks and five months. Mood stabilizers and 2nd generation antipsychotics are recommended as first-line treatment. Herein we report a young individual with B...

Alternative Titles

Full title

Pharmacogenomics and clinical response to antipsychotic treatment. Expectations vs reality

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_13dcae0323eb42c2b7c96a1d856a4262

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_13dcae0323eb42c2b7c96a1d856a4262

Other Identifiers

ISSN

0924-9338

E-ISSN

1778-3585

DOI

10.1192/j.eurpsy.2023.2151

How to access this item